First relapse in patients with multiple myeloma: Outcomes and predictors

被引：0
|
作者：
Seth, Sukriti
Kapoor, Prashant
Buadi, Francis
Binder, Moritz
Cook, Joselle
Dispenzieri, Angela
Dingli, David
Fonder, Amie L.
Gertz, Morie A.
Gonsalves, Wilson I.
Hayman, Suzanne R.
Hwa, Lisa
Hobbs, Miriam A.
Kourelis, Taxiarchis
Leung, Nelson
Lin, Yi
Muchtar, Eli
Warsame, Rahma M.
Rajkumar, S. Vincent
Kumar, Shaji
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Mayo Clin, Div Hematol, Rochester, MN USA
[3] Mayo Clin, Dept Internal Med, Div Hematol, Rochester, MN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7558
引用
收藏
页数：1
相关论文
共 50 条
  • [1] OUTCOME OF PATIENTS WITH MULTIPLE MYELOMA FOLLOWING FIRST RELAPSE, AN IMWG STUDY
    Kumar, S.
    Moreau, P.
    Terpos, E.
    Hajek, R.
    Morgan, G.
    Lee, J. H.
    Knop, S.
    Chng, W. J.
    Richardson, P.
    Sonneveld, P.
    San Miguel, J.
    Hungria, V.
    Maiolino, A.
    Hoering, A.
    Chen, W. M.
    Hou, J.
    Beksac, M.
    Lahuerta, J. J.
    Leleu, X.
    Blade, J.
    Durie, B.
    HAEMATOLOGICA, 2012, 97 : 341 - 341
  • [2] Racial differences as predictors of outcomes in young patients with multiple myeloma
    Alicia Bao
    Qiuhong Zhao
    Elizabeth Merritt
    Naresh Bumma
    Srinivas Devarakonda
    Abdullah M. Khan
    Elvira Umyarova
    Ashley E. Rosko
    Don M. Benson
    Francesca Cottini
    Blood Cancer Journal, 12
  • [3] Racial differences as predictors of outcomes in young patients with multiple myeloma
    Bao, Alicia
    Zhao, Qiuhong
    Merritt, Elizabeth
    Bumma, Naresh
    Devarakonda, Srinivas
    Khan, Abdullah M.
    Umyarova, Elvira
    Rosko, Ashley E.
    Benson, Don M.
    Cottini, Francesca
    BLOOD CANCER JOURNAL, 2022, 12 (07)
  • [4] Combination therapy for first relapse of multiple myeloma
    Gourd, Elizabeth
    LANCET ONCOLOGY, 2018, 19 (11): : E587 - E587
  • [5] Predictors of Lenalidomide Refractory Relapse Timing With Newly Diagnosed Multiple Myeloma: A FIRST Trial Subanalysis
    Manier, Salomon
    Dimopoulos, Meletios
    Hulin, Cyrille
    Leleu, Xavier
    Delforge, Michel
    Weisel, Katja
    Mouro, Jorge
    Costa, Bruno
    Sturniolo, Michael
    Facon, Thierry
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 (09): : e297 - e306.e1
  • [6] POST RELAPSE OUTCOMES IN YOUNG PATIENTS WITH MULTIPLE MYELOMA IN THE ERA OF NOVEL AGENTS
    Vallumsetla, N.
    Kumar, S.
    Gertz, M.
    Painuly, U.
    Dispenzieri, A.
    Lacy, M.
    Buadi, F.
    Go, R.
    Dingli, D.
    Leung, N.
    Kyle, R.
    Rajkumar, V.
    Kapoor, P.
    HAEMATOLOGICA, 2015, 100 : 257 - 258
  • [7] Pomalidomide, Bortezomib, and Dexamethasone (PVd) for Chinese Multiple Myeloma Patients at First Relapse
    Qiu, Lugui
    An, Gang
    BLOOD, 2021, 138
  • [8] THALIDOMIDE AND DEXAMETHASONE AS SALVAGE THERAPY AT FIRST RELAPSE IN PATIENTS WITH MULTIPLE MYELOMA: ANALYSIS OF LONG-TERM CLINICAL OUTCOMES
    Zamagni, E.
    Petrucci, A.
    Tosi, P.
    Tacchetti, P.
    Brioli, A.
    Pantani, L.
    Perrone, G.
    Baccarani, M.
    Cavo, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 154 - 154
  • [9] Current Treatment Strategies for Multiple Myeloma at First Relapse
    Mavrothalassitis, Evangelos
    Triantafyllakis, Konstantinos
    Malandrakis, Panagiotis
    Gavriatopoulou, Maria
    Kleber, Martina
    Ntanasis-Stathopoulos, Ioannis
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (05)
  • [10] Outcomes after relapse from first autologous stem cell transplantation in multiple myeloma.
    Gonsalves, Wilson I.
    Gertz, Morie A.
    Dispenzieri, Angela
    Lacy, Martha
    Gupta, Vinay
    Singh, Preet Paul
    Hayman, Suzanne R.
    Buadi, Francis
    Dingli, David
    Kapoor, Prashant
    Rajkumar, Vincent
    Kumar, Shaji
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345